ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 28, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Alzheimer Disease
Interventions
DEVICE

Blood Brain Barrier (BBB) Disruption

Focal Ultrasound (FUS) involves the application of acoustic energy at low frequencies from over 1000 individual transducers into distinct targets to induce BBB disruption.

Trial Locations (10)

10065

ACTIVE_NOT_RECRUITING

Weill Cornell Medicine, New York

26506

ACTIVE_NOT_RECRUITING

West Virginia University Rockefeller Neuroscience Center, Morgantown

32608

RECRUITING

University of Florida Health Shands, Gainesville

33176

RECRUITING

Baptist Health South Florida & Florida International University, Miami

33316

RECRUITING

Broward Health Medical Center & The University of Florida, Fort Lauderdale

33484

RECRUITING

Delray Medical Center & Florida Atlantic University, Delray Beach

33612

RECRUITING

Tampa General Hospital, Tampa

34747

RECRUITING

Advent Health, Orlando

43210

ACTIVE_NOT_RECRUITING

The Ohio State University -Wexner Medical Center, Columbus

75390

ACTIVE_NOT_RECRUITING

University of Texas Southwestern Medical Center, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InSightec

INDUSTRY